543594 Stock Overview
Dipna Pharmachem Limited engages in the trading of pharmaceuticals in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Dipna Pharmachem Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹9.14 |
| 52 Week High | ₹29.35 |
| 52 Week Low | ₹8.00 |
| Beta | 0 |
| 1 Month Change | -17.88% |
| 3 Month Change | -24.65% |
| 1 Year Change | -42.52% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -72.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543594 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 1.2% | -4.1% | -2.5% |
| 1Y | -42.5% | 61.1% | 44.5% |
Return vs Industry: 543594 underperformed the Indian Healthcare industry which returned 61.1% over the past year.
Return vs Market: 543594 underperformed the Indian Market which returned 44.5% over the past year.
Price Volatility
| 543594 volatility | |
|---|---|
| 543594 Average Weekly Movement | 11.8% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 543594's share price has been volatile over the past 3 months.
Volatility Over Time: 543594's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Keyur Shah | www.dipnapharmachem.com |
Dipna Pharmachem Limited engages in the trading of pharmaceuticals in India. It offers industrial chemicals, pharmaceutical raw materials, solvent, excipients, APIs, and formulations. The company’s products are used in various applications, which includes pharmaceuticals, textiles, paints, chemicals, cosmetic, and animal feeds.
Dipna Pharmachem Limited Fundamentals Summary
| 543594 fundamental statistics | |
|---|---|
| Market cap | ₹196.21m |
| Earnings (TTM) | ₹11.70m |
| Revenue (TTM) | ₹1.25b |
18.8x
P/E Ratio0.2x
P/S RatioIs 543594 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543594 income statement (TTM) | |
|---|---|
| Revenue | ₹1.25b |
| Cost of Revenue | ₹1.20b |
| Gross Profit | ₹49.45m |
| Other Expenses | ₹37.75m |
| Earnings | ₹11.70m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 3.94% |
| Net Profit Margin | 0.93% |
| Debt/Equity Ratio | 71.9% |
How did 543594 perform over the long term?
See historical performance and comparison